Owens & Minor is focused on paying down debt and rethinking how it builds momentum in its “pure-play” Patient Direct business ...

Owens & Minor says it is in the final stages of selling its Products & Healthcare Services segment, says CEO Ed Pesicka.

Coliseum Capital, a ten-percent owner of Owens & Minor INC/VA/ (NYSE:OMI), has recently purchased shares of the company worth approximately $8.1 million. These purchases, executed between August 12 ...

UBS analyst Kevin Caliendo lowered the firm’s price target on Owens & Minor to $7 from $13 and keeps a Buy rating on the shares. Owens & Minor’s ...

Owens & Minor, Inc. faces financial distress with a 70% stock drop, weak margins, and strategic missteps. Click here to find out why OMI stock is a Hold.

Owens & Minor's canceled Rotech deal eases financial risks. Click to read a full investment analysis of OMI stock and why its ...

Shares of Owens & Minor (NYSE:OMI) fell on Monday after the company's 2025 outlook failed to meet analysts' expectation, while also missing Q2 earnings estimates. The company said it expects its full ...

Citigroup analyst Daniel Grosslight maintained Owens & Minor with a Buy and lowered the price target from $11 to $7. Baird ...

Owens & Minor missed EPS estimates in Q2, but sales and EBITDA grew as it advanced plans to sell one of its segments.

The company’s adjusted EBITDA from continuing operations increased to $96.6 million in the second quarter, compared to $91.1 million in the prior-year period. Owens & Minor has classified its Products ...

(OMI) on Monday reported a loss of $869.1 million in its second quarter. The Glen Allen, Virginia-based company said it had a ...

NYSE:OMI 1 Year Share Price vs Fair Value Explore Owens & Minor's Fair Values from the Community and select yours ...